Developer docs
API playgroundTry for free, no card

Search company profiles

Doppelherz Pharma

Full company profile

uuid002daec

Namestring
Doppelherz Pharma
Legal namestring
Doppelherz Pharma GmbH
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersFlensburg, Germany
HQ citystring
Flensburg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmacy-only medicines, chemical pharmaceuticals, herbal medicine products, pharmaceutical manufacturing, medicinal products
Industry2 codes
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Medicinal and Botanical Manufacturing325411
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmacy-only Medicines Sales
TypeOne Time License
Description

Doppelherz Pharma generates revenue through the sale of apothekenpflichtige (pharmacy-only) medicines, including chemically synthesized drugs and natural medicines. Sales are made exclusively through pharmacies, with distribution handled by parent company Queisser Pharma GmbH & Co. KG. Products are offered at attractive price-performance ratios.

doppelherzpharma.de
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Doppelherz Pharma GmbH manufactures a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) featuring modern and proven active ingredients and dosage forms in high-demand therapeutic areas. The range focuses on chemically synthesized pharmaceuticals supplemented by select natural medicines. Products are sold exclusively through pharmacies in Germany at attractive price-performance ratios, with professional pharmacist consultation provided at point of sale. Distribution is handled by the parent company Queisser Pharma GmbH & Co. KG.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Doppelherz Pharma GmbH operates as a subsidiary of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg, Germany. The company offers a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) distributed exclusively through pharmacies. The product range focuses on chemically-synthesized drugs complemented by select natural remedies, covering high-demand therapeutic indications. Distribution is managed through the parent company Queisser Pharma GmbH & Co. KG.

Product and service1 record
1Doppelherz Pharma Arzneimittel (Pharmacy-Only Medicines)
CategoryPharmaceuticals (Pharmacy-only medicines)
Description

A portfolio of pharmacy-only medications (apothekenpflichtige Arzneimittel) featuring modern and well-established active ingredients and dosage forms in high-demand therapeutic areas. The focus is on chemically synthesized medicines supplemented by select natural remedies. Products are available exclusively through pharmacies in Germany at an attractive price-performance ratio, with professional pharmacist consultation provided at point of sale. Distribution is managed by parent company Queisser Pharma GmbH & Co. KG.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Queisser Pharma GmbH & Co. KG
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Doppelherz Pharma GmbH is a subsidiary company of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg. Queisser Pharma handles the distribution and sales of Doppelherz Pharma products. Queisser Pharma is known as a manufacturer of high-quality dietary supplements, medical devices, and medicines with focus on traditional herbal remedies.

doppelherzpharma.de
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

German pharmaceutical company focused on branded pharmaceuticals and healthcare products sold predominantly through pharmacies; comparable in terms of product mix, German-only distribution, and pharmacy-led GTM.

TypeDirect peer
Description

Leading German generics and pharmaceutical manufacturer; sells chemically synthesized medicines through pharmacies in Germany with similar regulatory and channel dynamics as Doppelherz Pharma.

3Dr. Wolff Group
TypeDirect peer
Description

German family-owned manufacturer of pharmaceuticals, medical devices, and cosmetics distributed primarily through pharmacies; overlapping portfolio approach and pharmacy-channel focus make it a close comparable.

TypeDirect peer
Description

German pharmaceutical manufacturer specializing in traditional and natural/herbal medicines distributed through pharmacies; particularly relevant to Doppelherz Pharma's natural-medicine component and parent Queisser's herbal focus.

TypeBroad incumbent
Description

Global pharmaceutical giant with a large German pharmacy-distributed Consumer Health portfolio; broader and more diversified than Doppelherz Pharma but competes head-to-head in the same apothekenpflichtige categories.

TypeBroad incumbent
Description

German arm of Sanofi with a substantial pharmacy-channel OTC and prescription portfolio; overlaps with Doppelherz Pharma in pharmacy-distributed chemically synthesized medicines at a much larger scale.

TypeDirect peer
Description

German-headquartered pharmaceutical company specializing in generics and consumer health products sold primarily through pharmacies; directly comparable to Doppelherz Pharma's apothekenpflichtige, pharmacy-distributed model in Germany.

TypeBroad incumbent
Description

Global consumer healthcare company (formerly GSK Consumer Healthcare) with pharmacy-distributed OTC and self-care products across Germany; comparable end-channel and consumer-marketing approach, though with broader international reach.

TypeDirect peer
Description

Mid-sized German pharmaceutical manufacturer producing branded generics and OTC products for the pharmacy channel; similar scale, German market focus, and chemically-synthesized product orientation as Doppelherz Pharma.

TypeDirect peer
Description

German pharmacy-focused pharmaceutical company (Teva subsidiary) selling generic and established-molecule medicines through the Apotheke channel; closely comparable to Doppelherz Pharma's chemically synthesized, pharmacy-distributed portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration10 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Doppelherz Pharma

Pharmaceutical Manufacturingdoppelherzpharma.de

Doppelherz Pharma firmographics

Firmographics
Name
Doppelherz Pharma
Legal name
Doppelherz Pharma GmbH
Website
https://doppelherzpharma.de
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Doppelherz Pharma industry classification

Industry
Product category
Pharmaceutical Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Pharmacy-only medicines
  • Chemical pharmaceuticals
  • Herbal medicine products
  • Pharmaceutical manufacturing
  • Medicinal products

Where Doppelherz Pharma is headquartered

Location

Headquarters

HQ city
Flensburg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Doppelherz Pharma business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

  1. Pharmacy-only Medicines Sales: Doppelherz Pharma generates revenue through the sale of apothekenpflichtige (pharmacy-only) medicines, including chemically synthesized drugs and natural medicines. Sales are made exclusively through pharmacies, with distribution handled by parent company Queisser Pharma GmbH & Co. KG. Products are offered at attractive price-performance ratios.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Doppelherz Pharma product offering

Product offering

Core offering

Doppelherz Pharma GmbH manufactures a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) featuring modern and proven active ingredients and dosage forms in high-demand therapeutic areas. The range focuses on chemically synthesized pharmaceuticals supplemented by select natural medicines. Products are sold exclusively through pharmacies in Germany at attractive price-performance ratios, with professional pharmacist consultation provided at point of sale. Distribution is handled by the parent company Queisser Pharma GmbH & Co. KG.

Product overview

Doppelherz Pharma GmbH operates as a subsidiary of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg, Germany. The company offers a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) distributed exclusively through pharmacies. The product range focuses on chemically-synthesized drugs complemented by select natural remedies, covering high-demand therapeutic indications. Distribution is managed through the parent company Queisser Pharma GmbH & Co. KG.

Differentiator

Problem solved

Functional benefit

Products and services

  • Doppelherz Pharma Arzneimittel (Pharmacy-Only Medicines) A portfolio of pharmacy-only medications (apothekenpflichtige Arzneimittel) featuring modern and well-established active ingredients and dosage forms in high-demand therapeutic areas. The focus is on chemically synthesized medicines supplemented by select natural remedies. Products are available exclusively through pharmacies in Germany at an attractive price-performance ratio, with professional pharmacist consultation provided at point of sale. Distribution is managed by parent company Queisser Pharma GmbH & Co. KG.

Companies that use Doppelherz Pharma

Customer profile

Segments4 records

Ideal customer profiles2 records

Doppelherz Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration10 records

Doppelherz Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Queisser Pharma GmbH & Co. KGcoreChannel Partner/ Reseller/ DistributorDoppelherz Pharma GmbH is a subsidiary company of Queisser Pharma GmbH & Co. KG, both headquartered in Flensburg. Queisser Pharma handles the distribution and sales of Doppelherz Pharma products. Queisser Pharma is known as a manufacturer of high-quality dietary supplements, medical devices, and medicines with focus on traditional herbal remedies.

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Doppelherz Pharma competitors and assessment

Company assessment

Direct peers

  • Dermapharm Holding SE: German pharmaceutical company focused on branded pharmaceuticals and healthcare products sold predominantly through pharmacies; comparable in terms of product mix, German-only distribution, and pharmacy-led GTM.
  • Hexal AG (Sandoz): Leading German generics and pharmaceutical manufacturer; sells chemically synthesized medicines through pharmacies in Germany with similar regulatory and channel dynamics as Doppelherz Pharma.
  • Dr. Wolff Group: German family-owned manufacturer of pharmaceuticals, medical devices, and cosmetics distributed primarily through pharmacies; overlapping portfolio approach and pharmacy-channel focus make it a close comparable.
  • Klosterfrau Melisana GmbH: German pharmaceutical manufacturer specializing in traditional and natural/herbal medicines distributed through pharmacies; particularly relevant to Doppelherz Pharma's natural-medicine component and parent Queisser's herbal focus.
  • Stada Arzneimittel AG: German-headquartered pharmaceutical company specializing in generics and consumer health products sold primarily through pharmacies; directly comparable to Doppelherz Pharma's apothekenpflichtige, pharmacy-distributed model in Germany.
  • Mibe GmbH Arzneimittel: Mid-sized German pharmaceutical manufacturer producing branded generics and OTC products for the pharmacy channel; similar scale, German market focus, and chemically-synthesized product orientation as Doppelherz Pharma.
  • ratiopharm GmbH (Teva): German pharmacy-focused pharmaceutical company (Teva subsidiary) selling generic and established-molecule medicines through the Apotheke channel; closely comparable to Doppelherz Pharma's chemically synthesized, pharmacy-distributed portfolio.

Broad incumbents

  • Bayer AG (Consumer Health): Global pharmaceutical giant with a large German pharmacy-distributed Consumer Health portfolio; broader and more diversified than Doppelherz Pharma but competes head-to-head in the same apothekenpflichtige categories.
  • Sanofi-Aventis Deutschland GmbH: German arm of Sanofi with a substantial pharmacy-channel OTC and prescription portfolio; overlaps with Doppelherz Pharma in pharmacy-distributed chemically synthesized medicines at a much larger scale.
  • Haleon plc (Consumer Healthcare): Global consumer healthcare company (formerly GSK Consumer Healthcare) with pharmacy-distributed OTC and self-care products across Germany; comparable end-channel and consumer-marketing approach, though with broader international reach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Doppelherz Pharma social profiles

Digital presence

Doppelherz Pharma compliance and trust

Trust signal

Compliance1 record

Doppelherz Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Doppelherz Pharma leadership team

Management profile

Number of profiles

Profiles2 records

Doppelherz Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Doppelherz Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Doppelherz Pharma

What does Doppelherz Pharma do?

Doppelherz Pharma GmbH manufactures a portfolio of pharmacy-only medicines (apothekenpflichtige Arzneimittel) featuring modern and proven active ingredients and dosage forms in high-demand therapeutic areas. The range focuses on chemically synthesized pharmaceuticals supplemented by select natural medicines. Products are sold exclusively through pharmacies in Germany at attractive price-performance ratios, with professional pharmacist consultation provided at point of sale. Distribution is handled by the parent company Queisser Pharma GmbH & Co. KG.

Is Doppelherz Pharma a public or private company?

Doppelherz Pharma is a private company. It is classified as corporate owned and is currently operating.

When was Doppelherz Pharma founded?

Doppelherz Pharma was founded in -1. It employs 1 to 10 people.

Where is Doppelherz Pharma based?

Doppelherz Pharma is headquartered in Flensburg, Germany, in the Europe region.

How does Doppelherz Pharma make money?

One revenue line is on record: pharmacy-only Medicines Sales.

Who are Doppelherz Pharma's main competitors?

Direct peers on record are Dermapharm Holding SE, Hexal AG (Sandoz), Dr. Wolff Group, Klosterfrau Melisana GmbH, Stada Arzneimittel AG, Mibe GmbH Arzneimittel and ratiopharm GmbH (Teva). Broad incumbents are Bayer AG (Consumer Health), Sanofi-Aventis Deutschland GmbH and Haleon plc (Consumer Healthcare).

Does Doppelherz Pharma have an API?

No public API is recorded for Doppelherz Pharma.

What industry is Doppelherz Pharma in?

Doppelherz Pharma's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales